000 | 01320nam a2200493 a 4500 | ||
---|---|---|---|
001 | vtls000025880 | ||
003 | VRT | ||
005 | 20240802184153.0 | ||
008 | 1012060814s1991 enk 00000 eng d | ||
020 |
_a043443924X : _c£16.99 |
||
035 | _a(OCoLC)ocm24752080 | ||
035 | _aAUZ-2903 | ||
035 | _aVNU990033886 | ||
039 | 9 |
_a201608181650 _bhaianh _c201502072044 _dVLOAD _c201404250031 _dVLOAD _y201012061857 _zVLOAD |
|
040 | _aVNU | ||
041 | _aeng | ||
044 | _aGB | ||
082 | 1 | 4 |
_a338.7 _bLYN 1991 _214 |
090 |
_a338.7 _bLYN 1991 |
||
094 | _a65.8 | ||
095 | _a33(T)2 | ||
100 | 1 | _aLynn, Matthew | |
245 | 1 | 4 |
_aThe Billion dollar battle : _bMerck v Glaxo / _cMatthew Lynn |
260 |
_aLondon : _bWilliam Heinemann, _c1991 |
||
300 |
_a244 p. ; _c24 cm |
||
610 | 2 | 0 | _aGlaxo Group Research Limited. |
610 | 2 | 0 | _aMerck & Co. |
650 | 0 | _aCompetition | |
650 | 0 |
_aDrugs _xMarketing |
|
650 | 0 | _aPharmaceutical industry | |
650 | 0 |
_aPharmaceutical industry _xMoral and ethical aspects |
|
653 | _aCông nghiệp dược phẩm | ||
653 | _aCạnh tranh | ||
653 | _aDoanh Nghiệp | ||
653 | _aTiếp thị | ||
900 | _aTrue | ||
911 | _aV.B.Linh | ||
913 | _aLê Thị Thanh Hậu | ||
925 | _aG | ||
926 | _a0 | ||
927 | _aSH | ||
928 | _aAV-D2/00460 | ||
942 | _c1 | ||
999 |
_c334584 _d334584 |